Cetera Investment Advisers Bionano Genomics, Inc. Transaction History

Cetera Investment Advisers

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$0.57 - $1.16 $370 - $754	-650 Reduced 4.74%	13,055 $7,000
Q4 2022 Feb 14, 2023	SELL	$1.4 - $25.4 $61 - $1,117	-44 Reduced 0.32%	13,705 $20,000
Q3 2022 Nov 10, 2022	SELL	$0.36 - $36.0 $488 - $48,816	-1,356 Reduced 8.98%	13,749 $25,000
Q1 2022 May 13, 2022	SELL	$16.6 - $32.3 $99,600 - $193,799	-6,000 Reduced 28.43%	15,105 $39,000
Q4 2021 Feb 14, 2022	BUY	$29.9 - $61.2 $140,530 - $287,640	4,700 Added 28.65%	21,105 $63,000
Q3 2021 Nov 16, 2021	SELL	$51.4 - $68.2 $221,020 - $293,260	-4,300 Reduced 20.77%	16,405 $90,000
Q2 2021 Aug 13, 2021	BUY	$44.1 - $84.0 $295,470 - $562,800	6,700 Added 47.84%	20,705 $152,000
Q1 2021 May 17, 2021	BUY	$47.0 - $155.7 $658,235 - $2.18 Million	14,005 New	14,005 $113,000

4.97K

Ticker BNGO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 290,140,000
Market Cap $81.2M
Description
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

Stay updated on Cetera Investment Advisers with notifications on news.